Today, Mithra has two complementary platforms powered by a unique CDMO facility:
its innovative E4-based pipeline and its portfolio of complex therapeutics

Estetrol (E4) based projects

Complex therapeutics

Mithra CDMO

Latest news

Conversion of a portion of the loans from Highbridge and Whitebox and Information on the total number of voting rights (denominator)

10 August 2022/by Célia Berlemont

Mithra obtains funding for up to EUR 100 million from existing investors and repurchases EUR 34.1 million of its convertible bonds due 2025 at a discount to par

8 August 2022/by Célia Berlemont

Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®

8 August 2022/by Célia Berlemont

NEXTSTELLIS® oral contraceptive has been nominated for the 2022 Prix Galien USA Award for Best Pharmaceutical Agent

2 August 2022/by Célia Berlemont

See all press releases

Our reference website for the general public about women’s health

Articles, videos and advice from gynecologists on female related issues

gynandco

Subscribe to our mailing list